Infectious Diseases Market Research Report, Growth & Forecast

Publications found: 156
Sort by:

The 2027-2032 World Outlook for Gram-Positive Bacterial Infections

US$ 1,195.00

This study covers the world outlook for gram-positive bacterial infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earn...

January 2026 290 pages

The 2027-2032 World Outlook for Healthcare Acquired Infections

US$ 1,195.00

This study covers the world outlook for healthcare acquired infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

January 2026 288 pages

The 2027-2032 World Outlook for Herpes Simplex Virus Infections

US$ 1,195.00

This study covers the world outlook for herpes simplex virus infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

January 2026 288 pages

The 2027-2032 World Outlook for Hospital-Acquired Pneumonia Prevention

US$ 1,195.00

This study covers the world outlook for hospital-acquired pneumonia prevention across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

January 2026 291 pages

Global Acinetobacter Infections Treatment Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Acinetobacter Infections Treatment market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Acinetobacter is a group of...

January 2026 113 pages

Global Drugs for Herpes Labialis (Oral Herpes) Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Drugs for Herpes Labialis (Oral Herpes) market size is expected to reach $ 4013 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032). Herpes Labial...

January 2026 137 pages

Global Drugs for Malaria Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Drugs for Malaria market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Drugs for malaria or antimalarial medication...

January 2026 107 pages

Global Hospital-Acquired Pneumonia Prevention Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Hospital-Acquired Pneumonia Prevention market size is expected to reach $ 298 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032). Dental plaque i...

January 2026 104 pages

Dengue – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) 2026

US$ 2,999.00

The Dengue – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers i...

December 2025 218 pages

Fungal Otitis Externa Market 2026

US$ 2,999.00

The Fungal Otitis Externa Market was valued at in and is anticipated to reach by , at a CAGR of 0.028 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...

December 2025 218 pages

Group B Streptococcus (GBS) Market 2026

US$ 2,999.00

The Group B Streptococcus (GBS) Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...

December 2025 218 pages

Herpes Zoster Infection Treatment Market - 2022-2030

US$ 2,999.00

The Herpes Zoster Infection Treatment Market was valued at US$ 251.2 million in 2022 and is anticipated to reach US$ 331.0 million by 2030, at a CAGR of 0.036 from 2026 to 2032. The report delivers in...

December 2025 219 pages

Herpes Zoster Oticus Market 2026

US$ 2,999.00

The Herpes Zoster Oticus Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

December 2025 219 pages

Invasive Fungal Infection Market 2026

US$ 2,999.00

The Invasive Fungal Infection Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

December 2025 207 pages

Listeriosis Market 2026

US$ 2,999.00

The Listeriosis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...

December 2025 218 pages

Pseudomonas Aeruginosa Infection Treatment Market - 2022-2030

US$ 2,999.00

The Pseudomonas Aeruginosa Infection Treatment Market was valued at USD 1331.51 million in 2022 and is anticipated to reach USD 2019.81 million by 2030, at a CAGR of 0.054 from 2026 to 2032. The repor...

December 2025 217 pages

Shigella Infections Market 2026

US$ 2,999.00

The Shigella Infections Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

December 2025 220 pages

Monkeypox Market - 2023-2031

US$ 2,999.00

The Monkeypox Market was valued at US$ 93.17 million in 2023 and is anticipated to reach US$ 264 million by 2031, at a CAGR of 0.1016 from 2026 to 2032. The report delivers in-depth insights into key...

December 2025 217 pages

Chikungunya Fever Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (ELISA Based Assays, Serological Tests, Virological Tests), By Treatment (Allopathy, Homeopathy, Ayurveda, Others), By End User (Hospital & Clinics, Ambulatory Surgical care, Others), By Region and Competition, 2020-2030F

US$ 4,500.00

The Global Chikungunya Fever Market, valued at USD 493.23 Million in 2024, is projected to experience a CAGR of 7.28% to reach USD 751.91 Million by 2030. The Global Chikungunya Fever Market encompass...

December 2025 185 pages

Acinetobacter Infections Treatment Market 2026

US$ 2,999.00

The Acinetobacter Infections Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...

November 2025 210 pages

Bacteremia Market 2026

US$ 2,999.00

The Bacteremia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...

November 2025 210 pages

Bacterial Infectious Diseases Therapeutics Market - 2021-2031

US$ 2,999.00

The Bacterial Infectious Diseases Therapeutics Market was valued at USD 75.8 billion in 2021 and is anticipated to reach by 2031, at a CAGR of 0.082 from 2026 to 2032. The report delivers in-depth ins...

November 2025 207 pages

Bacterial Pharyngitis Drugs Market - 2023-2031

US$ 2,999.00

The Bacterial Pharyngitis Drugs Market was valued at US$ 2.5 billion in 2023 and is anticipated to reach US$ 3.6 billion by 2031, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth ins...

November 2025 217 pages

Bacterial Pneumonia Market - 2022-2030

US$ 2,999.00

The Bacterial Pneumonia Market was valued at US$ 2.7 billion in 2022 and is anticipated to reach US$ 5.0 billion by 2030, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights in...

November 2025 210 pages

Botulism Market 2026

US$ 2,999.00

The Botulism Market was valued at in and is anticipated to reach by , at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...

November 2025 243 pages

Bubonic Plague Market 2026

US$ 2,999.00

The Bubonic Plague Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...

November 2025 243 pages

Candidiasis Therapeutics Market 2026

US$ 2,999.00

The Candidiasis Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.053 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...

November 2025 200 pages

Chagas Disease Market - 2023-2031

US$ 2,999.00

The Chagas Disease Market was valued at US$ 268 million in 2023 and is anticipated to reach US$ 467 million by 2031, at a CAGR of 0.072 from 2026 to 2032. The report delivers in-depth insights into ke...

November 2025 219 pages

Cutaneous And Systemic Leishmaniasis Market 2026

US$ 2,999.00

The Cutaneous And Systemic Leishmaniasis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...

November 2025 207 pages

Cytomegalovirus Infection Treatment Market - 2023-2031

US$ 2,999.00

The Cytomegalovirus Infection Treatment Market was valued at US$ 516.36 million in 2023 and is anticipated to reach US$ 858.65 million by 2031, at a CAGR of 0.067 from 2026 to 2032. The report deliver...

November 2025 210 pages

Ebola Virus Infection Market 20262031

US$ 2,999.00

The Ebola Virus Infection Market was valued at in and is anticipated to reach by 2031, at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

November 2025 200 pages

Genital Herpes Treatment Market - 2023-2031

US$ 2,999.00

The Genital Herpes Treatment Market was valued at US$ 1,143.19 million in 2023 and is anticipated to reach US$ 1,669.81 million by 2031, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-de...

November 2025 220 pages

H3N2 Infection Drugs Market 2026

US$ 2,999.00

The H3N2 Infection Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

November 2025 220 pages

Helicobacter Pylori Infection Therapeutics Market 2026

US$ 2,999.00

The Helicobacter Pylori Infection Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynami...

November 2025 220 pages

Herpes Labialis Treatment Market 2026

US$ 2,999.00

The Herpes Labialis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

November 2025 220 pages

Herpes Simplex Virus Treatment Market 2026

US$ 2,999.00

The Herpes Simplex Virus Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...

November 2025 220 pages

Hospital Infection Therapeutics Market 2026

US$ 2,999.00

The Hospital Infection Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.026 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...

November 2025 243 pages

India, Pakistan and Cambodia Tuberculosis Treatment Market 2026

US$ 2,999.00

The India, Pakistan and Cambodia Tuberculosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key mark...

November 2025 200 pages

Influenza Therapeutics Market 2026

US$ 2,999.00

The Influenza Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...

November 2025 243 pages

Invasive Pneumococcal Disease Market 2026

US$ 2,999.00

The Invasive Pneumococcal Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...

November 2025 243 pages

Neglected Tropical Disease Treatment Market 2026

US$ 2,999.00

The Neglected Tropical Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

November 2025 207 pages

Pharyngitis Treatment Market - 2022-2030

US$ 2,999.00

The Pharyngitis Treatment Market was valued at US$ 2.3 billion in 2022 and is anticipated to reach US$ 3.2 billion by 2030, at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights...

November 2025 210 pages

Pneumonia Therapeutics Market 2026

US$ 2,999.00

The Pneumonia Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...

November 2025 217 pages

Respiratory Syncytial Virus (RSV) Therapeutics Market - 2022-2020

US$ 2,999.00

The Respiratory Syncytial Virus (RSV) Therapeutics Market was valued at USD 1.2 billion in 2022 and is anticipated to reach 1 billion by 2020, at a CAGR of 0.102 from 2026 to 2032. The report delivers...

November 2025 218 pages

Schistosomiasis Drugs Market - 2021-2031

US$ 2,999.00

The Schistosomiasis Drugs Market was valued at USD 70.4 million in 2021 and is anticipated to reach by 2031, at a CAGR of 0.038 from 2026 to 2032. The report delivers in-depth insights into key market...

November 2025 220 pages

Skin and Soft Tissue Infections Market - 2023-2031

US$ 2,999.00

The Skin and Soft Tissue Infections Market was valued at US$ 11,283.71 million in 2023 and is anticipated to reach US$ 21,708.55 million by 2031, at a CAGR of 0.088 from 2026 to 2032. The report deliv...

November 2025 207 pages

Smallpox Treatment Market 2026

US$ 2,999.00

The Smallpox Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional g...

November 2025 243 pages

Traveler's Diarrhea Market 2026

US$ 2,999.00

The Traveler's Diarrhea Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

November 2025 223 pages

Varicella Zoster (HHV-3) Infections Treatment Market - 2023-2031

US$ 2,999.00

The Varicella Zoster (HHV-3) Infections Treatment Market was valued at US$ 1,799.42 million in 2023 and is anticipated to reach US$ 2,523.90 million by 2031, at a CAGR of 0.043 from 2026 to 2032. The...

November 2025 219 pages

Visceral Leishmaniasis Treatment Market 2026

US$ 2,999.00

The Visceral Leishmaniasis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...

November 2025 217 pages

Filters

Search

Publishers

11
20
1
12
11
25
2
66
2
1
5

Regions

156

Price

Date

Pages

Offers